GOLD BOND LABS FEMARA 50 TABS

Femara (letrozole) is a medication commonly used in the treatment of breast cancer, particularly in postmenopausal women. It works by inhibiting the enzyme aromatase, which is involved in the production of estrogen. Since some breast cancer cells rely on estrogen to grow, reducing the amount of estrogen in the body can help slow or stop the growth of certain types of breast cancer.

Gold Bond Labs is a pharmaceutical manufacturer, but Femara is typically marketed under the brand name by Novartis. If you’re referring to a generic version of Femara made by Gold Bond Labs, it would contain the same active ingredient—letrozole—and be used for similar indications, including:

1. Breast Cancer Treatment: As part of adjuvant therapy following surgery for estrogen receptor-positive breast cancer.
2. Ovarian Cancer: In some cases, Femara is also used for advanced ovarian cancer.
3. Infertility Treatment: Femara may be used off-label to induce ovulation in women with infertility due to polycystic ovary syndrome (PCOS).

Dosage typically starts at 2.5 mg daily, but it’s essential to follow your healthcare provider’s recommendations. Side effects may include hot flashes, joint pain, fatigue, and increased risk of osteoporosis.

If you have specific questions about how Femara is marketed or used in your case, it’s always best to consult a healthcare provider or pharmacist.